Supply Chain Intelligence

Biodexa Pharmaceuticals Plc Supply Chain

BDRX supply chain intelligence for Biodexa Pharmaceuticals Plc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

BDRX ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

14Suppliers
0Customers
1Debt Items
20Related Chains

Biodexa Pharmaceuticals Plc Suppliers

TickerNameConfidenceEvidence
CGON CG Oncology, Inc. 72% Reciprocal relationship from CGON graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from CGON g…
CGON CG Oncology, Inc. 72% l lawsuits challenging state authority to regulate prescription drug payment limits. Furthermore, in December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the state…
CNSP CNS Pharmaceuticals, Inc. 72% Reciprocal relationship from CNSP graph: Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing a…
CNSP CNS Pharmaceuticals, Inc. 72% ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund has invested in approximately 30 private co…
CRSP CRISPR Therapeutics AG 72% ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund has invested in approximately 30 private co…
CRSP CRISPR Therapeutics AG 72% Reciprocal relationship from CRSP graph: Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing a…
PSTV Plus Therapeutics, Inc. 72% ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund has invested in approximately 30 private co…
PSTV Plus Therapeutics, Inc. 72% Reciprocal relationship from PSTV graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from PSTV graph: Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceutic…
RXRX Recursion Pharmaceuticals, Inc. 72% Reciprocal relationship from RXRX graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from RXRX graph: Reciprocal relationship from BDRX graph: l lawsuits challenging state author…
RXRX Recursion Pharmaceuticals, Inc. 72% l lawsuits challenging state authority to regulate prescription drug payment limits. Furthermore, in December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the state…
SABSW SABSW 72% Reciprocal relationship from SABSW graph: Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing …
SABSW SABSW 72% ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund has invested in approximately 30 private co…
TARA Protara Therapeutics, Inc. 72% Reciprocal relationship from TARA graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from TARA graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from TARA g…
TARA Protara Therapeutics, Inc. 72% l lawsuits challenging state authority to regulate prescription drug payment limits. Furthermore, in December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the state…

Biodexa Pharmaceuticals Plc Customers

No clients on recordNo downstream customers found in our database for Biodexa Pharmaceuticals Plc.

Biodexa Pharmaceuticals Plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
BDRX-DEBT Debt stack $81,285 90% Market cache reports total debt of $81,285.

Biodexa Pharmaceuticals Plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Biodexa Pharmaceuticals Plc.

Biodexa Pharmaceuticals Plc Ownership

HolderNameConfidenceEvidence
BDRX-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 25; value $110; as of 2026-03-31.
BDRX-OWNER-RHUMBLINE-ADVISERS Rhumbline Advisers 95% 13F/ownership overlay lists Rhumbline Advisers; shares held 5; value $22; as of 2025-12-31.
BDRX-OWNER-HILTON-HEAD-CAPITAL-PARTNERS-LLC Hilton Head Capital Partners, LLC 95% 13F/ownership overlay lists Hilton Head Capital Partners, LLC; shares held 6; value $26; as of 2026-03-31.
BDRX-OWNER-HRT-FINANCIAL-LP HRT Financial LP 95% 13F/ownership overlay lists HRT Financial LP; shares held 2,117; ownership 0.28%; value $9,357; as of 2025-12-31.
BDRX-OWNER-SBI-SECURITIES-CO-LTD SBI Securities Co., Ltd. 95% 13F/ownership overlay lists SBI Securities Co., Ltd.; shares held 151; ownership 0.02%; value $667; as of 2026-03-31.
BDRX-OWNER-SABBY-MANAGEMENT-LLC Sabby Management, LLC 95% 13F/ownership overlay lists Sabby Management, LLC; shares held 38,132; ownership 5.11%; value $168,543; as of 2025-12-31.
BDRX-OWNER-GAMMA-INVESTING-LLC Gamma Investing LLC 95% 13F/ownership overlay lists Gamma Investing LLC; shares held 2,756; ownership 0.37%; value $12,181; as of 2026-03-31.
BDRX-OWNER-ARMISTICE-CAPITAL-LLC Armistice Capital, LLC 95% 13F/ownership overlay lists Armistice Capital, LLC; shares held 20,000; ownership 2.68%; value $88,400; as of 2025-12-31.

Biodexa Pharmaceuticals Plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SABSW SAB Biotherapeutics, Inc. 100.00 1 ['supplier']
AAUAF Almaden Minerals Ltd. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
BANL CBL International Limited 100.00 2
AUGO Aura Minerals Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
EBS Emergent BioSolutions Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
AZN AstraZeneca PLC 100.00 2
RYAOF Ryanair Holdings plc 100.00 2
ALGM Allegro MicroSystems, Inc. 100.00 2
DEO Diageo plc 100.00 2
TARA Protara Therapeutics, Inc. 100.00 1 ['supplier']
CTNM Contineum Therapeutics, Inc. 100.00 2
CBAN Colony Bankcorp, Inc. 100.00 2
CGON CG Oncology, Inc. 100.00 1 ['supplier']
ALCY Alchemy Investments Acquisition Corp 1 100.00 2
CNSP CNS Pharmaceuticals, Inc. 100.00 1 ['supplier']
ACET Adicet Bio, Inc. 100.00 2
View BDRX supply chain intel →

Explore the full interactive supply chain map for Biodexa Pharmaceuticals Plc.

Open BDRX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map